Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. If you miss a scheduled appointment for a dose of this medicine, contact your doctor for further instructions.
Live vaccines (severe)
Etanercept (severe)
Adalimumab (severe)
Clozapine (severe)
Folic Acid (severe)
Warfarin (severe)
This medicine is used in a combination with other medicines for the treatment of cancer of the colon and the rectum.
This medicine is used in a combination with other medicines for the treatment of cancer of the breast.
This medicine is used in a combination with other medicines for the treatment of cancer of the stomach (gastric adenocarcinoma).
This medicine is used in a combination with other medicines for the treatment of cancer of the pancreas.
Diarrhea
Nausea and Vomiting
Mouth sores
Loss of appetite
Watery eyes
Photophobia
Change in taste/ Metallic taste
Discoloration along veins
Decrease in blood cell count (severe)
Drying and cracking of skin
Hyperpigmentation
Darkening of skin where radiation was received (Radiation recall)
Hair loss or thinning of the hair
Discoloration and loss of nails (severe)
Redness, swelling and pain of palms or soles
Chest pain or discomfort (severe)
Vision disturbances (severe)
Injection site redness, bruising, or sores (severe)
Difficulty in swallowing (severe)
Bloody or coffee colored vomit (severe)
Unusual bleeding or bruising (severe)
Bleeding and irritation of nose (severe)
This medicine is not recommended for use in patients with a known allergy to 5-5-FU 50mg|ml Injection 10s , capecitabine, or any other inactive ingredient present along with it.
medicine
This medicine is not recommended for use in patients with severe liver or kidney damage due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with an active severe infection since it may worsen the patient’s condition.
This medicine is not recommended for use in patients with an active nutritional deficiency or malnourishment due to the increased risk of worsening of the patient’s condition.
This medicine is not recommended for use in patients with an inherited deficiency of an enzyme called Dihydropyrimidine dehydrogenase since the risks of toxicity and fatal adverse effects are significantly higher in such patients.